Allogene Therapeutics, Inc. Annual Earnings Per Share, Basic in USD/shares from 2019 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Allogene Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2019 to 2023.
  • Allogene Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.32 USD/shares, a 13.5% increase year-over-year.
  • Allogene Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -1.54 USD/shares, a 32.2% increase year-over-year.
  • Allogene Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -2.09 USD/shares, a 12.2% increase from 2022.
  • Allogene Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -2.38 USD/shares, a 77.6% decline from 2021.
  • Allogene Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -1.34 USD/shares, a 49% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$2 +$0.29 +12.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 -$2 -$1 -77.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 -$1 +$1.29 +49% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-14
2020 -$3 -$1 -43.7% Jan 1, 2020 Dec 31, 2020 10-K/A 2024-03-14
2019 -$2 Jan 1, 2019 Dec 31, 2019 10-K 2022-02-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.